Zhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate

Bulletin Express

Jul 03

Zhaoke Ophthalmology Limited disclosed that it repurchased 7,500 ordinary shares on 3 July 2026 via on-exchange transactions at prices ranging from HKD 2.58 to HKD 2.62, for a total consideration of HKD 19,610.25.

Including this latest transaction, the company has bought back 1.70 million shares since the repurchase mandate was approved on 15 May 2026. The aggregate repurchases represent 3.10 % of the 54.87 million-share limit authorised by that mandate and about 0.31 % of the current issued share base.

All 1.70 million shares are earmarked for cancellation but were still outstanding as at 3 July 2026, leaving the company’s issued share capital unchanged at 548.75 million shares.

Under Hong Kong Stock Exchange rules, Zhaoke Ophthalmology is subject to a moratorium on new share issuance or treasury-share sales until 3 August 2026.

The board confirmed that all repurchases complied with applicable listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1194242134"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194242134\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194242134?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194242134","market":"hk","top_or_hot":-1,"title":"Zhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate","media":"Bulletin Express","content":"<p>Zhaoke Ophthalmology Limited disclosed that it repurchased 7,500 ordinary shares on 3 July 2026 via on-exchange transactions at prices ranging from HKD 2.58 to HKD 2.62, for a total consideration of HKD 19,610.25.</p>\n<p>Including this latest transaction, the company has bought back 1.70 million shares since the repurchase mandate was approved on 15 May 2026. The aggregate repurchases represent 3.10 % of the 54.87 million-share limit authorised by that mandate and about 0.31 % of the current issued share base.</p>\n<p>All 1.70 million shares are earmarked for cancellation but were still outstanding as at 3 July 2026, leaving the company’s issued share capital unchanged at 548.75 million shares.</p>\n<p>Under Hong Kong Stock Exchange rules, Zhaoke Ophthalmology is subject to a moratorium on new share issuance or treasury-share sales until 3 August 2026.</p>\n<p>The board confirmed that all repurchases complied with applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-03 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhaoke Ophthalmology Limited disclosed that it repurchased 7,500 ordinary shares on 3 July 2026 via on-exchange transactions at prices ranging from HKD 2.58 to HKD 2.62, for a total consideration of HKD 19,610.25.</p>\n<p>Including this latest transaction, the company has bought back 1.70 million shares since the repurchase mandate was approved on 15 May 2026. The aggregate repurchases represent 3.10 % of the 54.87 million-share limit authorised by that mandate and about 0.31 % of the current issued share base.</p>\n<p>All 1.70 million shares are earmarked for cancellation but were still outstanding as at 3 July 2026, leaving the company’s issued share capital unchanged at 548.75 million shares.</p>\n<p>Under Hong Kong Stock Exchange rules, Zhaoke Ophthalmology is subject to a moratorium on new share issuance or treasury-share sales until 3 August 2026.</p>\n<p>The board confirmed that all repurchases complied with applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06622","symbol_name":"兆科眼科-B","start_time":0,"source_url":"","article_id":"1194242134","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194242134","pubTimestamp":1783072997,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhaoke Ophthalmology Limited disclosed that it repurchased 7,500 ordinary shares on 3 July 2026 via on-exchange transactions at prices ranging from HKD 2.58 to HKD 2.62, for a total consideration of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06622":"兆科眼科-B"},"translate_title":"兆科眼科7月3日回购7500股；自授权以来累计回购170万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06622":1},"content_text":"Zhaoke Ophthalmology Limited disclosed that it repurchased 7,500 ordinary shares on 3 July 2026 via on-exchange transactions at prices ranging from HKD 2.58 to HKD 2.62, for a total consideration of HKD 19,610.25.\nIncluding this latest transaction, the company has bought back 1.70 million shares since the repurchase mandate was approved on 15 May 2026. The aggregate repurchases represent 3.10 % of the 54.87 million-share limit authorised by that mandate and about 0.31 % of the current issued share base.\nAll 1.70 million shares are earmarked for cancellation but were still outstanding as at 3 July 2026, leaving the company’s issued share capital unchanged at 548.75 million shares.\nUnder Hong Kong Stock Exchange rules, Zhaoke Ophthalmology is subject to a moratorium on new share issuance or treasury-share sales until 3 August 2026.\nThe board confirmed that all repurchases complied with applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}